CD4 and COVID-19: At 3 months post COVID-19, we have observed strong and persistent Omicron specific CD4+ memory T cells in hospitalised individuals in particular, and a significant proportion of CoV-TCRs targeting epitopes along the SARS-CoV-2 genome.